Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
45 participants
OBSERVATIONAL
2022-01-10
2024-01-10
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
This knowledge could have an important impact both on the symptomatological expression of the disorder, its recognition, and also on the management of the patient. The investigators aim to study the evolution over time of the sensory profile of depressed subjects hospitalized using the ASSP. The behavioral responses of individuals with sensory processing disorder may be related to the coping strategies of these individuals with their living environment. In a second step, the investigators will study the second step the sensory profile of subjects with depression according to their coping strategies, their living environment and their clinical characteristics (anxiety (anxiety, psychomotor slowing, self-esteem, anhedonia).
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Sensory and Psychomotor Profile in Depression
NCT04031937
Modeling and Predicting Real World Behavior Using Mobile Sensor Data on Patients With Major Depressive Disorder
NCT02499094
Neuronal Responses to Social Feedback in Major Depressive Disorder
NCT02180607
Clinical and Neurobiological Profile Predictive of Pejorative Outcome of Depression
NCT03690856
Stress Sensitivity and Reward Responsivity in Depression
NCT02798094
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Secondary objectives
* Objective 1: To describe at V1 and V2, the sensory profiles according to the clinical characteristics (anxiety, depression, psychomotor slowing, self-esteem, anhedonia); a difference in the relationship between the clinical scales and the quadrants (AASP) at V2 and V1 could be observed.
* Objective 2: To look for a difference in sensory profile at V2 according to clinical improvement
* Objective 3: To compare, at V1, the distribution of processing patterns of sensory profiles for each quadrant of the AASP, according to coping styles (CISS).
* Objective 4: To compare the distribution of processing patterns of sensory profiles sensory profiles for each quadrant of the AASP, according to socio-demographic characteristics: gender, age group, professional category, type of type of housing, environment, family situation
* Objective 5: To look for a difference in the distribution of the processing patterns sensory profiles between the first inclusion visit (V1) and 3 months (V2), according to the type of drug treatment (molecules and classes) and non (psychotherapy, relaxation, rTMS, ECT) Inclusion criteria
* Male or female, 18 to 65 years of age
* who have given informed consent
* with a diagnosis of a major depressive disorder according to the DSM-5 criteria
* in full hospitalization for less than 10 days in the care units of the Esquirol Hospital
Non inclusion criteria
* Psychiatric comorbidity (personality disorder, addiction other than tobacco, eating disorder, bipolar disorder, obsessive-compulsive disorder, schizophrenia and related disorders)
* Sensory or neurological disability
* Inability to understand the questionnaires and information related to the study
* Hospitalization under constraint, pregnancy, subjects under guardianship or curatorship, lack of social protection
Outcome Measures Primary endpoints
\- AASP at V1 and V2 Secondary endpoints
1. AASP, HARS, HAM-D, CORE, EES-10, SHAPS at V1 and V2
2. AASP, HAM-D at V2
3. AASP, ISSC
4. AASP scores and socio-demographic characteristics (age, sex ratio, living environment, family status, housing)
5. AASP scores and treatments at V1 and V2
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
AASP
assessment by scales
Assessment from many scales: AASP, HARS, HDRS, CORE, EES, CISS, SHAPS at V1 Assessment from many scales: AASP, HARS, HDRS, CORE, EES, SHAPS at V2
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
assessment by scales
Assessment from many scales: AASP, HARS, HDRS, CORE, EES, CISS, SHAPS at V1 Assessment from many scales: AASP, HARS, HDRS, CORE, EES, SHAPS at V2
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* who have given informed consent
* with a diagnosis of a major depressive disorder according to the DSM-5 criteria
* in full hospitalization for less than 10 days in the care units of the Esquirol Hospital
Exclusion Criteria
* Proven sensory or neurological disability
* Inability to understand the questionnaires and information related to the study
* Hospitalization under constraint, pregnancy, subjects under guardianship or curatorship, lack of social protection
18 Years
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Centre Hospitalier Esquirol
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Aude Paquet
Principal Investigator, Psychomotor Therapist
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
CH Esquirol
Limoges, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CHEsquirol
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.